NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-187-1995-1-PCT-01 Production of Infectious Respiratory Syncytial Virus From Cloned Nucleotide Sequences PCT PCT COMB PCT/US1996/015524 Expired
NIAID E-187-1995-1-JP-04 PRODUCTION OF ATTENUATED PARAINFLUENZA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES JP National Stage 1997-513678 Abandoned
NCI E-093-1996-0-US-01 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES US 60/026,816 Abandoned
NIAID E-049-1998-0-US-01 3'GENOMIC PROMOTER REGION AND POLYMERASE GENE MUTATIONS RESPONSIBLE FOR ATTENUATION IN VIRUSES OF THE ORDER DESIGNATED MONONEGAVIRALES US 60/026,823 Abandoned
NCI E-221-1995-0-PCT-02 MHC-CLASS II RESTRICTED MELANOMA ANTIGENS AND THEIR USE IN THERAPEUTIC METHODS PCT PCT PCT/US1996/015346 Expired
NHGRI E-135-1996-0-US-01 METHOD FOR PRODUCING RETROVIRUS RNA PACKAGING CASSETTES AND AMPLIED IN THE CYTOPLASM BY AUTOCATALYTIC TOGAVIRUS VECTORS US 60/026,666 Abandoned
NCI E-201-1994-1-US-03 DIMERIC ARYLISOQUINOLINE ALKALOIDS AND SYNTHESIS METHODS THEREOF US DIV 08/721,084 5786482 Abandoned PDF
NIDDK E-138-1995-0-PCT-02 PEPTIDE INHIBITOR FOR VIRAL PROTEASE DERIVED FROM THE TRANSFRAME REGION OF THE GAG-POL GENE PCT PCT PCT/US1996/015304 Expired
NEI E-015-1995-1-CA-03 CONTAINER FOR DRYING BIOLOGICAL SAMPLES, METHOD OF MAKING SUCH CONTAINER, AND METHOD OF USING SAME CA National Stage 2232673 Abandoned
NEI E-015-1995-1-DE-05 STERILE LYOPHILIZATION CONTAINER DE EP 96933897.9 Abandoned
NEI E-015-1995-1-FR-06 STERILE LYOPHILIZATION CONTAINER FR EP 96933897.9 Abandoned
NEI E-015-1995-1-IT-08 STERILE LYOPHILIZATION CONTAINER IT EP 96933897.9 Abandoned
NEI E-015-1995-1-GB-07 STERILE LYOPHILIZATION CONTAINER GB EP 96933897.9 Abandoned
NEI E-015-1995-1-EP-04 STERILE LYOPHILIZATION CONTAINER EP National Stage 96933897.9 Abandoned
NEI E-015-1995-2-US-01 CONTAINER FOR DRYING BIOLOGICAL SAMPLES, METHOD OF MAKING SUCH CONTAINER, AND METHOD OF USING SAME US CIP 08/717,114 5958778 Abandoned PDF
NEI E-015-1995-1-AU-02 STERILE LYOPHILIZATION CONTAINER AU National Stage 72456/96 Abandoned
NEI E-015-1995-1-PCT-01 CONTAINER FOR DRYING BIOLOGICAL SAMPLES, METHOD OF MAKING SUCH CONTAINER, AND METHOD OF USING SAME PCT PCT COMB PCT/US1996/015371 Expired
NIAID E-176-1996-0-US-01 HIV-1 THERAPY WITH IL-2 AND ANTI-TNF ANTIBODY US ORD 08/716,107 Abandoned
NINDS E-132-1996-0-US-01 IMMUNOTOXIN (MAB-RICIN) FOR THE TREATMENT OF FOCAL MOVEMENT DISORDERS US 60/027,458 Abandoned
NIAID E-001-1996-0-EP-04 NEUTRALIZING MONOCLONAL ANTIBODIES TO RESPIRATORY SYNCYTIAL VIRUS EP National Stage 96933810.2 Abandoned
NIAID E-001-1996-0-PCT-02 NEUTRALIZING MONOCLONAL ANTIBODIES TO RESPIRATORY SYNCYTIAL VIRUS PCT PCT PCT/US1996/014937 Expired
NIAID E-001-1996-0-CA-03 NEUTRALIZING MONOCLONAL ANTIBODIES TO RESPIRATORY SYNCYTIAL VIRUS CA National Stage 2230116 Abandoned
NIDCR E-171-1996-0-US-01 TARGETING ANTIGENTS TO THE MHC CLASS I PROCESSING PATHWAY WITH AN ANTHRAX TOXIN FUSION PROTEIN US 60/025,270 Abandoned
NCI E-231-1995-3-US-02 EVALUATION AND TREATMENT OF PATIENTS WITH PROGRESSIVE IMMUNOSUPPRESSION US DIV 08/714,596 5889143 Expired PDF
NCI E-220-1995-0-PCT-02 IMMUNOTHERAPEUTIC METHODS USING TUMOR ANTIGENIC PEPTIDES COATED ON CELLS AND VACCINES MADE THEREOF PCT PCT PCT/US1996/014704 Expired
NCI E-035-1994-1-NZ-16 ISOLATION OF CELLULAR MATERIAL UNDER MICROSCOPIC VISUALIZATION NZ National Stage 282276 Abandoned
NCI E-002-1993-0-US-03 COLON MUCOSA GENE HAVING DOWN-REGULATED EXPRESSION IN COLON ADENOMAS AND ADENOCARCINOMAS US DIV 08/711,928 5831015 Abandoned PDF
NIDDK E-145-1995-0-US-01 USE OF FUNCTIONAL N-METHYLE-D-ASPARTATE ANTAGONISTS TO AMELIORATE OR PREVENT AMINOGLYCOSIDE-INDUCED OTOTOXICITY US ORD 08/712,477 Abandoned
NIDCR E-066-1996-0-US-01 AAV4 VECTOR AND USES THEREOF US 60/025,934 Abandoned
NINDS E-249-1989-0-US-03 CLONED GENES FOR HUMAN DOPAMINE D2 RECEPTORS AND CELL LINES EXPRESSING SAME US DIV 08/709,298 6214615 Expired PDF
NIEHS E-215-1995-0-PCT-02 COMPOSITIONS COMPRISING VITAMIN F PCT PCT PCT/US1996/015205 Expired
NCI E-167-1996-0-US-01 METHOD OF STIMULATING AN IMMUNE RESPONSE US ORD 60/025,882 Abandoned
NCI E-170-1996-0-US-01 THERAPEUTIC CHEMOKINE ANTAGONISTS US 60/024,708 Abandoned
NCI E-186-1995-0-CA-02 MUTANT AEQUOREA VICTORIA FLUORESCENT PROTEINS HAVING INCREASED CELLULAR FLUORESCENCE
gp 		CA ORD 2184763 Abandoned
NINDS E-231-1994-2-US-01 METHOD OF REDUCING PERIVASCULAR LESIONS USING INSULIN-LIKE GROWTH FACTOR I US ORD 08/705,820 5965531 Abandoned PDF
NIMH E-178-1996-0-US-01 DELETION OF LYSOGENY GENES AND TOXIN GENES FROM BACTERIOPHAGE USED IN THE EPIDEMIOLOGIC CONTROL OF BACTERIAL ILLNESS US 60/019,392 Abandoned
NIMH E-179-1996-0-US-01 THERAPEUTIC USE OF PHAGE EXPRESSING TOXIN-BINDING AND/OR CYTOKINE- BINDING PROTEINS AND ELIMINATION OF GENES ASSOCIATED WITH LYSOGENY US 60/025,167 Abandoned
NCI E-046-1994-0-EP-06 FUSION PROTEINS THAT INCLUDE ANTIBODY AND NONANTIBODY PORTIONS EP National Stage 95908666.1 Abandoned
NCI E-025-1996-1-US-01 CYTOCHROME P-450 REPORTER GENE US ORD 08/697,329 5726041 Expired PDF
NCI E-025-1996-0-PCT-02 CYTOCHROME P450 REPORTER GENE PCT PCT PCT/US1996/013622 Expired
NCI E-068-1993-1-AU-03 METHODS OF ASSESSING MHC CLASS I EXPRESSION AND PROTEINS CAPABLE OF MODULATING CLASS I EXPRESSION AU National Stage 68600/96 Abandoned
NCI E-068-1993-1-PCT-02 METHODS OF ASSESSING MHC CLASS I EXPRESSION AND PROTEINS CAPABLE OF MODULATING CLASS I EXPRESSION PCT PCT PCT/US1996/013715 Expired
NCI E-068-1993-1-JP-06 METHODS OF ASSESSING MHC CLASS I EXPRESSION AND PROTEINS CAPABLE OF MODULATING CLASS I EXPRESSION JP National Stage 1997-509576 Abandoned
NCI E-068-1993-1-EP-05 METHODS OF ASSESSING MHC CLASS I EXPRESSION AND PROTEINS CAPABLE OF MODULATING CLASS I EXPRESSION EP National Stage 96929056.8 Abandoned
NCI E-068-1993-1-CA-04 METHODS OF ASSESSING MHC CLASS I EXPRESSION AND PROTEINS CAPABLE OF MODULATING CLASS I EXPRESSION CA National Stage 2229938 Abandoned
NCI E-335-1994-1-US-01 Method of Screening for Agents that Delay a Cell Cycle and Composition s Comprising Era and an Analog of Wild-Type Era US 60/023,353 Abandoned
NIDDK E-175-1995-1-US-01 GATED RF PREAMPLIFIER FOR USE IN PULSED RADIOFREQUENCY ELECTRON PARAMAGNETIC RESONANCE AND MRI US ORD 08/699,383 5828216 Expired PDF
NCI E-143-1996-0-US-01 NOVEL DNA: LIPOSOME COMPLEXES FOR INCREASED SYSTEMIC DELIVERY AND GENE EXPRESSION US 60/024,386 Abandoned
NCI E-206-1995-3-CA-03 FUNCTIONAL ROLE OF ADRENOMEDULLIN (AM) AND THE GENE-RELATED PRODUCT (PAMP) IN HUMAN PATHOLOGY AND PHYSIOLOGY CA National Stage 2229741 Abandoned
NCI E-206-1995-3-AU-02 FUNCTIONAL ROLE OF ADRENOMEDULLIN (AM) AND THE GENE-RELATED PRODUCT (PAMP) IN HUMAN PATHOLOGY AND PHYSIOLOGY AU National Stage 67765/96 Abandoned